Home » Consumer Health

190 posts categorized "Consumer Health"

July 7, 2014

Hormel Acquiring Muscle Milk Highlights Importance of Protein Trend

 

Hormel’s acquisition of Muscle Milk manufacturer Cytosport is another in a series of ambitious moves by the company in recent years and highlights the importance of sports nutrition as a category of consumer health. The ready to drink protein segment will grow twice as fast as the overall sports nutrition category and massive opportunities exist outside of the US where this category is untapped. This could be the first of many acquisitions in sports nutrition as protein continues to be hot trend in packaged food and drink. 

Watch on Youtube

June 27, 2014

Correcting Contradictions: Restoring OTC Coverage to Health Spending Accounts in the US

Mark StrobelAnalyst Insight by Mark Strobel - Consumer Health Analyst

Ballooning health care expenditure is an increasingly large burden for economies around the world. The problem is especially worrisome in the US, in part due to the high price of health goods and medical services. As a result, the US governing agencies are enacting policies that attempt to reign in health care spend and reduce costs. This objective is a cornerstone of the Affordable Care Act (AFA), as the name implies, which was signed into law in March 2010. However, under the AFA, the vast majority of over-the-counter remedies (OTCs) are no longer eligible for purchase with tax exempt health spending accounts. This effectively raises the price of these products, which is a direct contradiction of one of the primary goals of the AFA.  Restoring OTC coverage is a key legislative goal for several organizations and political representatives, and while it will correct an inconsistent approach to the health care policy, its overall impact on the US OTC market will likely be limited.

A Growing Hardship

Burgeoning health care expenditure is a growing issue worldwide. Consumers spent US$3.9 trillion globally on health goods and medical services in 2013, which is up 3% year-on-year and more than double from just 20 years ago (using constant terms to discount inflation). The US is particularly afflicted by this hardship, accounting for 60% of the global health care expenditure or US$2.4 trillion. According to the World Bank, health expenditure derives 17.9% of the US gross domestic product, which is most of all countries tracked. On a per capita basis, consumers in the US spent on average US$7,491 on health goods and medical services in 2013, or thirteen times more than the global average. This number, already up nearly US$700 from 2008, is only expected to grow with the aging population and the increased prevalence of non-communicable chronic diseases.

Continue reading "Correcting Contradictions: Restoring OTC Coverage to Health Spending Accounts in the US" »

June 15, 2014

Euromonitor to Speak at XV FederSalus Convention

Marchio FederSalusDate: 26th June, 2014

Location: Milan, Italy

Event Description: This event will explore the prospects for dietary supplements in the global market and how to deal with the challenges of internationalization. The debate focuses on the opportunities and challenges of the global market and the trends for food supplements. It will also discuss the points of difference between the different geopolitical areas, international regulatory scenarios with a focus towards homogeneous geographical areas, processes and flows of internationalization.

Link: http://www.federsalus.it//news.php?id=1076

Filippo BattainiSpeaker’s Name: Filippo Battaini, Retailing Analyst, Euromonitor International

View Filippo Battaini's profile on LinkedIn

Presentation Title: Global Opportunities and Prospects: Countries, Products and Channels

Presentation Description: This presentation will identify the market potential for vitamins and dietary supplements in South East Asian middle economies, China and United Arab Emirates. It will further analyse the main distribution channels in these regions and the opportunities that multichannel retailing, online retailing and direct selling can offer, with concrete examples of how companies have entered and operate in these markets.

一般用医薬品のインターネット販売制度改正

EURO_NT_Yukino.Kawabata_LThumb川端 雪乃,  リサーチアナリスト

一般用医薬品のインターネット販売に関する新たな制度が6月12日に施行されました。

最高裁判所の判決による一般用医薬品のネット販売解禁を受け、新制度はネット販売の安全性を確立するものとされています。

ネット販売事業者は、新たなサービスや付加価値を提供して対応していく必要があります。

MP3としてダウンロード

Internet Sales of Over-the-Counter Drugs in Japan Expected to Perform Well

EURO_NT_Yukino.Kawabata_LThumbWith Yukino Kawabata, Research Analyst

The recent lift on the ban of online over-the-counter drug sales in Japan has led to public concern about lack of regulation, so starting on June 12 stricter laws went into place to regulate these sales. Despite the new laws, online retailers such as Amazon Japan are selling OTC drugs for cheaper than pharmacies and drug stores, leading some physical retailers to offer services such as next day delivery. Overall, internet sales of OTC drugs should perform well in the coming years due to Japan’s active and aging population.

Download as an MP3

June 11, 2014

Consumer Health Developments in North Africa

ChrisSchmidtAnalyst Insight by Chris Schmidt - Consumer Health Analyst

View Chris Schmidt's profile on LinkedIn

With emerging market focus shifting from the once vaunted Brazil, Russia, India and China (BRIC), The Middle East and Africa is gaining clout as a potential growth engine for the future. Within the region, North Africa – namely Algeria, Egypt, Morocco and Tunisia – offers an exciting, and challenging, opportunity. While the area’s political instability has spooked some producers, its relatively sizeable markets and generally rosy growth outlook will continue to draw interest from the consumer health industry.

Demographic Opportunities Face Political Headwinds

North Africa is an intriguing region, in that it offers a number of advantageous socio-economic characteristics. Algeria, Egypt, Morocco and Tunisia all feature higher per household annual disposable incomes than the average of the Middle East and Africa region and have populations that are expected to grow faster than much of the rest of the developing world in the next two decades. These factors have helped drive consumer health sales and will be important contributors to the expected 4% retail value sales CAGR those four markets will combine for through 2018.

Continue reading "Consumer Health Developments in North Africa" »

June 10, 2014

Asian Health and Wellness Trends in Food and Beverages

Asia saw strong double digit growth in medical health in 2011 and consumers are increasingly aware that “Prevention is better than cure.”  Therefore, consumers are beginning to make lifestyle choices through exercising and the way they eat and drink in order to stay healthy. Together with all the other factors which I have just mentioned, consumers are taking health eating and drinking as an approach to reduce the demand for expensive health care and high medical costs in the future.Asia-health-giveaway

Continue reading "Asian Health and Wellness Trends in Food and Beverages" »

June 4, 2014

The Future of Probiotics

Probiotics will perform even better in 2014 than 2013, coming off a strong year of sales of supplements and yoghurt. While these two categories are responsible for the majority of sales of probiotics, researchers are testing probiotics as a way to treat a variety of issues including infant eczema, colic and allergies, so the future of probiotics may stretch beyond these two categories.

Watch on Youtube

June 1, 2014

Global Opportunities for Proton Pump Inhibitors

ChrisSchmidtAnalyst Insight by Chris Schmidt - Consumer Health Analyst

View Chris Schmidt's profile on LinkedIn

As Pfizer pushes forth its rollout of the recently switched Nexium (esomeprazole 20 mg), the over-the-counter (OTC) world’s attention is focused on the proton pump inhibitor (PPI) category. While not as widely available as other indigestion and heartburn remedies, PPI’s were the fastest-growing digestive remedies category from 2008 to 2013. With Nexium’s predecessor Prilosec (omeprazole 20mg) having achieved blockbuster OTC status for competitor Procter & Gamble, Nexium has the potential to reshape the category and push PPI sales to new heights across the globe.

Strong Growth, Small Footprint

Posting a 5% CAGR, PPI’s were the fastest-growing category in digestive remedies globally from 2008 to 2013. The growth was driven primarily by new product launches, including Prevacid (Novartis AG) in 2009 and Zegerid (Merck & Co Inc) in 2010 in the US, which is the world’s largest PPI market by far. In 2013, the US accounted for more than three-quarters of all global sales. While growth in the US was steady through the 2000’s, as the new launches converted many previous consumers of the prescription versions, the surging popularity of private label  – which are priced at a significant discount in most retailers – has weighed on overall value sales growth since 2010. Though Procter & Gamble and Novartis continue to spend heavily on promoting their Prilosec and Prevacid brands, both are expected to lose further ground to private label and could be further cannibalized by consumers switching to Pfizer’s Nexium 24HR, which rolled out in the US on May 27, 2014.

 

Continue reading "Global Opportunities for Proton Pump Inhibitors" »

May 26, 2014

Euromonitor to Speak at Benefiq 2014

Benefiq-2014_Desc_AN_4C

Event: Benefiq 2014: International Rendezvous on Health Ingredients

Dates: September 23-25, 2014

Location: Quebec City Convention Center, Quebec, Canada

Event Description: Renowned speakers will lecture on current hot topics, a broad range of health ingredients suppliers will showcase their products, innovative technologies will be presented, and business meetings and networking opportunities will abound.

Continue reading "Euromonitor to Speak at Benefiq 2014" »

Subscribe

 RSS Feed

Receive New Posts via Email:

 

Join us on...


View our YouTube Channel Follow Euromonitor on Twitter Become a Fan on Facebook Connect with Euromonitor on LinkedIn




Filter by Category

Filter by Geography

Filter by Industry

Recent Posts

Hormel Acquiring Muscle Milk Highlights Importance of Protein Trend

Correcting Contradictions: Restoring OTC Coverage to Health Spending Accounts in the US

Euromonitor to Speak at XV FederSalus Convention

一般用医薬品のインターネット販売制度改正

Internet Sales of Over-the-Counter Drugs in Japan Expected to Perform Well

Consumer Health Developments in North Africa

Asian Health and Wellness Trends in Food and Beverages

The Future of Probiotics

Global Opportunities for Proton Pump Inhibitors

Euromonitor to Speak at Benefiq 2014